Contact-tracing apps ‘could improve COVID vaccination strategy’Targeting people for COVID-19 vaccination using contract-tracing apps could be a shortcut to achieving herd immunity in the Share XContact-tracing apps ‘could improve COVID vaccination strategy’https://pharmaphorum.com/news/contact-tracing-apps-could-improve-covid-vaccination-strategy/
Scientific study finds music can ‘tune out pain’A study has found that listening to a specially composed music track can achieve “clinically significant” reductions in Share XScientific study finds music can ‘tune out pain’https://pharmaphorum.com/news/scientific-study-finds-music-can-tune-out-pain/
FDA clears AI-powered prostate cancer detection softwareSoftware that can help pathologists detect prostate cancer from slides of biopsies more effectively has been approved by Share XFDA clears AI-powered prostate cancer detection softwarehttps://pharmaphorum.com/news/fda-clears-ai-powered-prostate-cancer-detection-software/
Lundbeck taps Inscopix’ brain-mapping camera tech for CNS researchDanish drugmaker Lundbeck has teamed up with Inscopix – the developer of a technology that can film neurons Share XLundbeck taps Inscopix’ brain-mapping camera tech for CNS researchhttps://pharmaphorum.com/news/lundbeck-taps-inscopix-brain-mapping-camera-tech-for-cns-research/
Algorithm spots people vulnerable to COVID despite jabsUK researchers say an algorithm can identify people who remain at risk of developing serious COVID-19, despite having Share XAlgorithm spots people vulnerable to COVID despite jabshttps://pharmaphorum.com/news/algorithm-calculates-people-vulnerable-to-covid-despite-jabs/
Luminopia’s digital therapy for lazy eye aces clinical trialA digital therapeutic (DTx) for amblyopia – sometimes known as lazy eye – has been shown to improve Share XLuminopia’s digital therapy for lazy eye aces clinical trialhttps://pharmaphorum.com/news/luminopias-digital-therapy-for-lazy-eye-aces-clinical-trial/
AI aims to prevent unneeded treatment for deep vein thrombosisResearchers in the UK are working on an artificial intelligence (AI) algorithm to help diagnose deep vein thrombosis Share XAI aims to prevent unneeded treatment for deep vein thrombosishttps://pharmaphorum.com/news/ai-aims-to-prevent-unneeded-treatment-for-deep-vein-thrombosis/
Coalition formed to represent patient interests in digital healthNot enough is being done to ensure that patient voices are included in policymaking around digital health, says Share XCoalition formed to represent patient interests in digital healthhttps://pharmaphorum.com/news/coalition-formed-to-represent-patient-interests-in-digital-health/
Zoll agrees $538m deal to buy sleep apnoea specialist ItamarItamar Medical was on the acquisition trail itself earlier this year, buying Spry Health to extend its sleep Share XZoll agrees $538m deal to buy sleep apnoea specialist Itamarhttps://pharmaphorum.com/news/zoll-agrees-538m-deal-to-buy-sleep-apnoea-specialist-itamar/
